Onconetix, Inc. and Realbotix LLC. have signed a share exchange agreement pursuant to which Onconetix will acquire 100% of the issued and outstanding equity interests of Realbotix.
Realbotix LLC is focused on researching, designing, building and manufacturing AI-powered, highly customisable humanoid robotics.
The robots are used for customer-facing roles in industries such as healthcare, education, hospitality and entertainment.
The transaction, which has been unanimously approved by the boards of directors of both Onconetix and Realbotix Parent, is subject to customary closing conditions.
Upon closing of the proposed transaction, Onconetix will acquire all the issued and outstanding equity interests of Realbotix in exchange for newly issued shares of common stock of Onconetix.
Realbotix Corp CEO, Andrew Kiguel, said: “Realbotix confidently places its robots, with customized embedded AI, into public venues to act autonomously and unscripted.
“Our vision system has advanced to be able to interpret emotional visual cues, situations and even read and see colors.”
IntraLogisteX is heading to Dallas, Texas in 2026, bringing the industry’s specialist trade show and conference to one of North America’s key logistics hubs. Join supply chain, manufacturing, robotics and automation leaders on 16–17 September 2026 at the Kay Bailey Hutchison Convention Center and explore hands-on demos, new launches and practical ideas to boost efficiency and scalability.
